A recurring and urgent theme across the regional health reports from July 2026 is the “steep attrition” within the Tuberculosis (TB) care system. While health facilities are successfully screening thousands of people, a significant number of potential patients are being “lost” between the initial suspicion of the disease and the start of life-saving treatment.
The Acholi “Drop-off”
In the Acholi sub-region, the integration of TB screening into routine care appeared strong, with nearly 89% of all outpatient visitors being screened. This effort identified 531 presumptive cases—people showing clear symptoms of the disease. However, the journey toward health stalled there. Of those hundreds of suspected cases, only 34 were confirmed as new or relapse diagnoses, and a mere 19 patients actually began treatment that week. This means that only about 56% of diagnosed patients in the region started their medication, a gap that health officials describe as a “significant finding” requiring immediate case-tracking follow-up.
Mbale’s “Data Maze” and Enrollment Gaps
In the Mbale region, the challenge is further complicated by “extensive errors” in data submission and systemic failures to enroll detected patients into care. The regional bulletin highlights several specific instances where the system failed:
- Joy Hospice Deliverance Church detected two new cases but failed to start them on treatment.
- Busime Health Centre III in Busia detected two cases but did not enroll either of them into care.
- Mbale Regional Referral Hospital reported 21 new TB cases but was only able to bacteriologically confirm two of them.
These “missed opportunities” are often buried under data errors, making it difficult for regional teams to produce timely and accurate epidemiological bulletins.
The Linkage Struggle in Karamoja
The Karamoja sub-region faces its own hurdles in connecting patients to care, particularly in Nabilatuk, which recorded the highest TB burden in the region. While screening rates remained high at 98%, the “linkage to treatment” rate dropped to 72% in late July. In districts like Nabilatuk and Moroto, health officials specifically identified cases where patients were diagnosed but never linked to a treatment program, leaving them at risk and potentially continuing the spread of the disease within their communities.
A Call for Active Tracking
The shared story across these regions is one of missed connections. The sources suggest that the immediate focus for surveillance teams must shift from just “finding” cases to tracing the drop-off. By identifying exactly where patients are lost—whether during the diagnostic referral, the GeneXpert testing turnaround, or the final enrollment in treatment—health teams hope to close the gap and ensure that every person screened is a person saved
